Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 527 is a member of the zinc finger protein family, characterized by Cys2His2-type zinc finger domains that enable sequence-specific binding to DNA. ZNF527 functions as a transcription factor, potentially regulating gene expression by binding to cis-regulatory regions of genes transcribed by RNA polymerase II. This protein has many orthologues across species and several transcript variants, and may have diverse roles in cellular processes, but its precise biological functions and disease associations remain largely uncharacterized. There is no evidence supporting its status as a direct therapeutic target or involvement in drug interactions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 527 (ZNF527).